These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 377513)

  • 21. [Non-A, non-B hepatitis].
    Scalise G; Mura MS; Andreoni G; Cuccuru G; Stangoni A
    Ann Sclavo; 1980; 22(3):374-84. PubMed ID: 6264869
    [No Abstract]   [Full Text] [Related]  

  • 22. [Acute hepatitis B and non-A, non-B hepatitis. A year's case series: epidemiological and clinical aspects].
    Verani DA; Isoardi MA; Fontana S
    Minerva Dietol Gastroenterol; 1988; 34(2):97-100. PubMed ID: 3140073
    [No Abstract]   [Full Text] [Related]  

  • 23. [The value of serologic study methods in viral hepatitis].
    Frösner GG
    Med Klin Prax; 1982 Apr; 77(8):18-27. PubMed ID: 7078516
    [No Abstract]   [Full Text] [Related]  

  • 24. [Markers of hepatitis B virus in chronic liver diseases].
    Maleev A; Ognianov M; Ninova D
    Ter Arkh; 1987; 59(7):13-7. PubMed ID: 3672351
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study.
    Nasseri-Moghaddam S
    Arch Iran Med; 2009 Jul; 12(4):437; author reply 437-8. PubMed ID: 19566369
    [No Abstract]   [Full Text] [Related]  

  • 26. Serological markers of hepatitis B infection.
    Burrell CJ
    Clin Gastroenterol; 1980 Jan; 9(1):47-63. PubMed ID: 6994952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Liver function tests: analysis of HB antigens and antibodies--HBs, HBc, and HBe antigens and antibodies].
    Moritoh T; Saito K; Kasukawa R
    Rinsho Byori; 1986 Jun; 34 Spec No 67():101-8. PubMed ID: 3534350
    [No Abstract]   [Full Text] [Related]  

  • 28. Dynamics of serum markers in the different course of hepatitis B virus (HBV) infection.
    Stancek D; Blaskovicová H; Hajnická V; Husár K; Holenová Z; Mathernová V; Sudová J; Laktis K; Spanárová V
    Acta Virol; 1987 May; 31(3):234-42. PubMed ID: 2888287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [IgM antibodies against hepatitis B core antigens, anti-HBc-IgM. Their diagnostic significance].
    Esteban R; Guardia J; Buti M; Esteban JI; Rodrigo MJ; Jardí R; Hernández JM; Bacardí R
    Med Clin (Barc); 1984 Oct; 83(11):437-9. PubMed ID: 6503413
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical aspects of severe forms of serum hepatitis type B].
    Ketiladze ES; Farber NA; Zhilina NN; Vorozhbieva TE; Savitskiĭ GI
    Klin Med (Mosk); 1980 Jan; 58(1):46-52. PubMed ID: 6966013
    [No Abstract]   [Full Text] [Related]  

  • 32. [Highly sensitive methods for the serological,diagnosis of hepatitis B and their clinico-epidemiological significance].
    Botsvadze ESh; Aleksishvili MM; Gegeshidze TN; Mosakhlishvili NG
    Ter Arkh; 1990; 62(2):79-82. PubMed ID: 2336630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin M hepatitis B core antibody: to titer or not to titer? to use or not to use?
    Gitnick G
    Gastroenterology; 1983 Mar; 84(3):653-5. PubMed ID: 6822334
    [No Abstract]   [Full Text] [Related]  

  • 34. [Active chronic hepatitis caused by the B virus (ACH-B). Analysis of a series of cases].
    Romeo F; Russo A; Liuzzo P
    Recenti Prog Med; 1980 Dec; 69(6):644-69. PubMed ID: 6166033
    [No Abstract]   [Full Text] [Related]  

  • 35. Laboratory diagnosis of viral hepatitis.
    Ganem D; Vyas GN
    Geriatrics; 1983 Mar; 38(3):97-103, 107-8. PubMed ID: 6402417
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serological markers correlated with hepatitis B virus. Study made predominantly in chronic hepatitis in children].
    Calzia R; Ciravegna B; Navone C; Fiorini R; Tolentino P
    Minerva Pediatr; 1981 Aug; 33(16):805-15. PubMed ID: 6273707
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antigens and antibodies in acute viral hepatitis caused by the B virus. Clinical significance].
    Malacco E; Iacono G; Risso F
    Minerva Med; 1979 Feb; 70(6):479-82. PubMed ID: 431867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Distribution of serologic markers of hepatitis B in a sample of the population of Cremona province].
    Romanini G; Bodini U; Pennacchio A; Cavalli P; Carpanelli R; Pecoroni L; Sampaoli G; Bini MG; D'Avossa A; Frosi A
    Riv Emoter Immunoematol; 1984; 31(2):165-73. PubMed ID: 6536097
    [No Abstract]   [Full Text] [Related]  

  • 39. [Selected indicators of hepatitis B in the blood serum during the first few days of hospitalization of patients with acute viral hepatitis].
    Rzeszowska G; Mazurek E; Mierzejewska I; Fijałka-Rymar M; Ignaciuk A
    Ann Univ Mariae Curie Sklodowska Med; 1987; 42():83-7. PubMed ID: 3154900
    [No Abstract]   [Full Text] [Related]  

  • 40. [Presence of anti-HBc antibodies in Australia-antigen-negative hepatitis].
    Vargas V; Ruiz J; Esteban R; Pedreira JD; Hernandez JM; Guardia J; Bacardi R
    Nouv Presse Med; 1979 Nov; 8(45):3756. PubMed ID: 534241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.